Bracebridge Capital, LLC - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 48 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.97 and the average weighting 1.9%.

Quarter-by-quarter ownership
Bracebridge Capital, LLC ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$655,714
-7.3%
428,5710.0%0.10%
-73.2%
Q2 2023$707,142
+44.7%
428,5710.0%0.39%
+198.5%
Q1 2023$488,571
+26.4%
428,5710.0%0.13%
+261.1%
Q4 2022$386,614
-22.8%
428,5710.0%0.04%
-59.1%
Q3 2022$501,000
+82.8%
428,5710.0%0.09%
+104.7%
Q2 2022$274,000
-75.5%
428,5710.0%0.04%
-48.2%
Q1 2022$1,119,000
-32.9%
428,5710.0%0.08%
-18.6%
Q4 2021$1,667,000
-10.8%
428,5710.0%0.10%
-38.2%
Q3 2021$1,869,000
+9.9%
428,5710.0%0.16%
+10.7%
Q2 2021$1,701,000
-23.7%
428,5710.0%0.15%
-22.8%
Q1 2021$2,229,000
-2.8%
428,5710.0%0.19%
-44.5%
Q4 2020$2,293,000
+10.1%
428,5710.0%0.35%
+4.2%
Q3 2020$2,083,0000.0%428,5710.0%0.33%
-45.2%
Q2 2020$2,083,000
+108.3%
428,5710.0%0.61%
+237.0%
Q1 2020$1,000,000
-50.0%
428,5710.0%0.18%
+12.4%
Q4 2019$2,000,000428,5710.16%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 9,810,958$11,479,000100.00%
Vahanian & Associates Financial Planning Inc. 695,258$813,0002.80%
Latash Investments, LLC 243,134$284,0000.23%
Bracebridge Capital, LLC 428,571$501,0000.09%
Running Point Capital Advisors, LLC 10,000$12,0000.01%
D.B. Root & Company, LLC 12,500$14,0000.01%
Schonfeld Strategic Advisors LLC 406,700$475,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 142,956$167,0000.00%
IFP Advisors, Inc 6,500$104,0000.00%
Financial Advocates Investment Management 27,000$32,0000.00%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders